Xellsmart Bio-pharmaceutical (suzhou) Co., Ltd.

This study tests a new treatment called XS228, made from stem cells, to help repair nerve damage in people who had a spinal cord injury 2 to 12 weeks ago. About 60 adults with severe but incomplete paralysis will receive either a single injection of XS228 into their spinal fluid …